L7 UNIVERSE: Implementation of L7|ESP™ LIMS for a GMP Cellular Therapy Manufacturing Facility

September 13, 2023

Participant:

Joshua Geary, IT Manager, Cell Manipulation Core Facility, Dana-Farber Cancer Institute

Information:

Over the past year, an L7 implementation team has worked with the to implement LIMS for the Connell and O’Reilly Families Cell Manipulation Core Facility at the Dana-Farber Cancer Institute. The compendium of the facility has been implemented in L7|ESP, 1/3 of the assays going paperless, as well as key product traceability workflow. In future releases, additional workflows will become paperless, testing instruments will be integrated, and the product disposition workflow will be captured in L7|ESP, leading into the implementation of L7’s manufacturing execution system implementation for standard of care and IND manufacturing.

 

wasdsprite11